Yael L. Maxwell

During #NYValves2025, Patrick O'Gara, Michael Borger, and @yaelmaxwell.bsky.social discussed how the FDA approval of asymptomatic TAVI has changed practice, with perspectives from the US and Europe. Watch the full episode of On Record here: www.tctmd.com/videos/on-re...

In this episode of Heart Sounds, our TCTMD journalists discuss the top news in cardiology for July. @lamckeown1.bsky.social @yaelmaxwell.bsky.social @toddneale.bsky.social www.tctmd.com/audio/top-ca...

I set up a Signal account if anyone would prefer to reach me there.

Cardiologists More Often Send Higher-Risk Patients for CAC Scans vs Generalists The decade-long, single-healthcare-system study gives insights into how physicians are using CAC tests and in which patients.

Whether a patient undergoes CAC screening depends on the type of doctor they see, with large sex differences observed over the past decade at a single healthcare system, according to retrospective data. #SCCT2025 #CardioSky

www.tctmd.com/news/cardiol...

Less Plaque With Intensive Medical Therapy vs Usual Care in INOCA: WARRIOR The serial imaging substudy shows that intensive therapy might change plaque morphology positively, researchers say.

Intensive medical therapy usual care for reducing noncalcified coronary plaque in women who have INOCA, according to results of a serial imaging subanalysis of the WARRIOR trial. #SCCT2025 #CardioSky @damini-d.bsky.social

www.tctmd.com/news/less-pl...

Defining Success in Medicine From patient satisfaction to making family and mentors proud, fellows tell TCTMD they feel fulfilled in a variety of ways.

New in the @tctmd.bsky.social Fellows in Focus Feed: Attendees at #Fellows2025 tell us how they define success in medicine. #FellowsForum #CardioSKy

www.tctmd.com/videos/defin... @abdullahalabcha.bsky.social

Leaders in Cardiac CT Look Back on 20 Years of Growth Despite Challenges A special session at SCCT was dedicated to the history of the field, but also explored future directions and unanswered questions.

Leaders in the field of cardiac CT celebrated 20 years of science, innovation, and overcoming challenges during a special session at the 2025 @scct-heart.bsky.social meeting. #SCCT2025 #CardioSky

www.tctmd.com/news/leaders...

AI-QCT Possibly Lessens Gap Between Ideal vs Actual Care for Patients at Risk of ASCVD The “hypothesis-generating” results show that the technology might improve use of preventive therapies, especially in women.

AI-QCT can potentially improve preventive care for patients, especially women, thought to be at risk for ASCVD, according to an analysis of the CERTAIN study. #SCCT2025 #CardioSky

www.tctmd.com/news/ai-qct-...

AI-Based Coronary Plaque Analysis Can Inform Management Beyond CCTA: DECIDE Registry The technology, which led to a shift in strategy more than half of the time, could save $719 per symptomatic patient over 10 years.

For symptomatic patients who’ve undergone CCTA, added knowledge gleaned from AI-CPA (@heartflow.bsky.social) changes the management strategy more than half the time, according to new data from the DECIDE registry.

tctmd.com/news/ai-base...
@cianpmccarthy.bsky.social #SCCT2025 #Cardiosky

Adding Coronary CT Angiography to Annual Firefighter Physicals Could Save Lives Scanning identified significant CAD in this high-risk population, even among those with zero CAC.

Among more than 300 young, fit firefighters, CCTA led to 3.6% undergoing a diagnostic cath and 28.6% being referred to a cardiologist for medical or lifestyle management. Among the 2/3 with 0 CAC, 83% had noncalcified plaque. #SCCT2025 #CardioSky

www.tctmd.com/news/adding-...

I’m excited to be in Montréal for #scct2025. Who else is here and what are you most looking forward to hearing about? (And where can I find the best poutine in town?😉)

Carbon Footprint of Surgical AVR Double the Size of TAVI’s The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

"It’s not so much that one therapy is better than another, but there are consequences to everything that we do," says Isaac George.

www.tctmd.com/news/carbon-... #cardiosky

Carbon Footprint of Surgical AVR Double the Size of TAVI’s The study isn’t intended to sway clinical decision-making, but to make doctors aware of the impact of their choices.

"It’s not so much that one therapy is better than another, but there are consequences to everything that we do," says Isaac George.

www.tctmd.com/news/carbon-... #CardioSky

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.

TEER with the Pascal system in patients with degenerative MR results in good early survival outcomes, significant reductions in MR, and improvements in quality of life, according to an analysis of the STS/ACC TVT Registry. #NYValves2025 #CardioSky

www.tctmd.com/news/good-ou...

Long-term Survival Better With TAVI Explant vs Redo: Medicare Data The procedures are not mutually exclusive, however, and should be considered on a patient-by-patient basis, a researcher says.

My 1st from #NYValves2025 (and my 1st time at this meeting!):

Surgical explant is associated with better long-term survival compared with redo TAVI in a population of Medicare patients requiring reintervention. @ShinFukuharaMD @DrBowdish @TsuyoshiKaneko1

www.tctmd.com/news/long-te...

On Record: Innovation in Cardiology Azeem Latib and Jose Calle Gordo discuss "me too" vs disruptive approaches.

What's more valuable in cardiology: iterative innovation or totally disruptive new technologies? I spoke with Azeem Latib and Jose Calle Gordo about this topic and more for @tctmd.bsky.social's #OnRecord. #CardioSky

www.tctmd.com/videos/on-re...

On Record: Putting Post-PCI DAPT Into Perspective Dominick Angiolillo sums up all the data on this key clinical question.

Anyone else have trouble keeping all the post-PCI DAPT data straight? I spoke with Dominick Angiolillo at #EuroPCR for our #OnRecord series to summarize where we are now and what questions remain. #CardioSky

www.tctmd.com/videos/on-re...

Rising Cardiac Mortality Since the COVID Era Raises Questions About Healthcare Delivery With new CVD treatments arriving each year, “there’s no reason why outcomes should be getting worse,” says Jason Wasfy.

Cardiac mortality rates have increased in Massachusetts annually since the start of the COVID-19 pandemic in 2020, with exaggerated seasonal patterns and upticks in at-home deaths, according to new population-based data. #CardioSky

www.tctmd.com/news/rising-...

On Record: Leaving a Legacy in Cardiovascular Medicine Davide Capodanno reflects on how he is able to serve the cardiology community through his role as the editor-in-chief at EuroIntervention.

At #EuroPCR, I sat down with @eurointervention.bsky.social EIC @dfcapodanno.bsky.social for @tctmd.bsky.social's #OnRecord to chat about what it means to leave a legacy in cardiovascular medicine.

www.tctmd.com/videos/on-re...

Early Coronary Function Testing Improves Quality of Life in ANOCA In the ILIAS ANOCA trial, using CFT to guide treatment according to ANOCA endotype led to larger QoL gains over 6 months.

Coronary function testing done during the index angiography in patients with ANOCA is not only feasible and safe but also can improve disease-related quality of life over time compared with standard care, according to data from ILIAS ANOCA #EuroPCR #CardioSky

www.tctmd.com/news/early-c...

IVL has become a standard lesion preparation method in calcified lesions in our cats lab and we use it almost daily. Reassuring that new data proves it safe. IMO we need to have some convincing clinical outcome data for this expensive device as well but this may require a huge trial. #cardiosky.

IVL Effective in Severely Calcified Lesions, Especially in Women EMPOWER-CAD and BALI reinforce the utility of coronary lithotripsy, but the effect on hard outcomes is still unclear.

Intravascular lithotripsy can safely aid in lesion preparation before PCI in patients with severe calcification and can lower the rate of postprocedural patient adverse outcomes, according to data from 2 new studies presented #EuroPCR. #CardioSky

www.tctmd.com/news/ivl-eff...

Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage Researchers say the data underscore the need for more aggressive surveillance of patients, even when AS is moderate AS.

Cardiac damage is present in 4 out of every 5 patients with asymptomatic AS and is tied to worse prognosis over time, but new EARLY TAVR data suggest that TAVI improves clinical outcomes regardless of the extent of that damage #EuroPCR #CardioSky

www.tctmd.com/news/early-t...

As day 2 of #EuroPCR begins, make sure to check out all of the @tctmd.bsky.social team coverage. #CardioSky @lamckeown1.bsky.social @michaeltctmd.bsky.social

www.tctmd.com/conference/e...

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data Current guidelines support culprit-only PCI in these cases, but the “hypothesis-generating” results suggest taking a closer look.

Immediate multivessel PCI offers similar survival out to 180 days when compared with culprit-only PCI among STEMI patients with cardiogenic shock, according to provocative new data from the DanGer Shock trial. #EuroPCR #CardioSky

www.tctmd.com/news/immedia...

Text reads "World Hypertension Day. 2005 projection: 29.5% of women worldwide will have hypertension in 2025. 2019 reality: 32% of females already had hypertension. The Lancet, 2005 / European Heart Journal, 2022"

20 years ago, research predicted 29.5% of women would have hypertension by 2025. By 2019, it was already 32%.

❌ Still underdiagnosed
❌ Still undertreated
❌ Still overlooked

It's time for change.

#WorldHypertensionDay

🔗www.thelancet.com/jo...
🔗academic.oup.com/eur...

Attention fellows, come find me during the next break outside the session room to participate in a video interview for @TCTMD’s #FellowsForum. #Fellows2025

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA Trialists should focus less on physician-defined outcomes and more on what matters to patients, Mario Gaudino says.

While spontaneous MIs are associated with worse quality of life both early and late, procedural MIs don’t appear to have a lasting impact on disease-specific QoL, according to new data from the invasive-management arm of the ISCHEMIA trial. #CardioSky

www.tctmd.com/news/procedu...

Four-Dimensional Flow CMR Shows Promise in Aortic Stenosis This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

4D flow CMR can more accurately estimate peak aortic valve velocities than traditional TTE in patients with aortic stenosis, according to data from the PREFER-CMR registry. #cardiosky

www.tctmd.com/news/four-di...

Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact The main message is that absolute levels of Lp(a) matter more than which genes may have caused them, Robert Clarke says.

Although the genes that affect Lp(a) in European and East Asian populations might vary, the downstream clinical effects that stem from high Lp(a) levels are similar, according to data from the UK and China. #CardioSky

www.tctmd.com/news/lpa-gen...